1. Kindly Furnish the status of introducing medication for Psoriasis based on Heterocyclic compounds as lipoxygenase inhibitors patent research work by Professor Reddanna Pallu and his Team of Hyderabad Central University.
2. Status as on 02-10-2023 for preclinical and clinical trials of Psoriasis medicine based on Heterocyclic compounds as lipoxygenase inhibitors patent research work by Professor Reddanna Pallu and his Team of Hyderabad Central University.
3.Status as on 02-10-2023 for preclinical and clinical trials by Dr Reddy Labs Team. If any pre/clinical trials completed, then furnish full details.Also furnish us what is the tentative time for releasing medicine or Psoriasis based on Heterocyclic compounds as lipoxygenase inhibitors patent research work by Professor Reddanna Pallu and his Team of Hyderabad Central University.